The efficacy of desvenlafaxine for improving functioning and quality of life measures in patients with major depressive disorder

被引：0
|
作者：
Soares, C.
Thase, M. [1 ]
Kornstein, S. [2 ]
Brisard, C. [3 ]
Septien-Velez, L. [3 ]
Germain, J. M. [3 ]
Pitrosky, B. [3 ]
Patroneva, A. [4 ]
Jiang, Q. [4 ]
Ninan, P. [4 ]
Ganguly, R. [4 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[3] Wyeth Ayerst Res, Paris, France
[4] Wyeth Ayerst Res, Collegeville, PA USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70478-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S342 / S343
页数：2
相关论文
共 50 条
  • [1] Improvement in functioning and quality of life measures in patients with major depressive disorder treated with desvenlafaxine
    Soares, C.
    Thase, M.
    Kornstein, S. G.
    Brisard, C.
    Septien-Velez, L.
    Germain, J. -M.
    Pitrosky, B.
    Patroneva, A.
    Jiang, Q.
    Ninan, P. T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 206 - 206
  • [2] Efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder: A pooled anlaysis
    Thase, M.
    Kornstein, S. G.
    Tummala, R.
    Germain, J. M.
    Jiang, Q.
    Ninan, P. T.
    Guico-Pabia, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 200 - 200
  • [3] An Integrated Analysis of the Efficacy of Desvenlafaxine Compared with Placebo in Patients with Major Depressive Disorder
    Thase, Michael E.
    Kornstein, Susan G.
    Germain, Jean-Michel
    Jiang, Qin
    Guico-Pabia, Christine
    Ninan, Philip T.
    CNS SPECTRUMS, 2009, 14 (03) : 144 - 154
  • [4] Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder
    Kamath, Jayesh
    DeMartinis, Nicholas
    Handratta, Venkatesh
    FUTURE NEUROLOGY, 2007, 2 (04) : 361 - 371
  • [5] The impact of fatigue and energy on work functioning and impairment in patients with major depressive disorder treated with desvenlafaxine
    Sarfati, David
    Evans, Vanessa C.
    Tam, Edwin M.
    Woo, Cindy
    Iverson, Grant L.
    Yatham, Lakshmi N.
    Lam, Raymond W.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (06) : 343 - 349
  • [6] Desvenlafaxine in the treatment of major depressive disorder
    Lourenco, Maria Teresa C.
    Kennedy, Sidney H.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 127 - 136
  • [7] Desvenlafaxine for the treatment of major depressive disorder
    Kornstein, Susan G.
    McIntyre, Roger S.
    Thase, Michael E.
    Boucher, Matthieu
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (10) : 1449 - 1463
  • [8] The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder
    Lam, Raymond W.
    Iverson, Grant L.
    Evans, Vanessa C.
    Yatham, Lakshmi N.
    Stewart, Kurtis
    Tam, Edwin M.
    Axler, Auby
    Woo, Cindy
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 203 : 55 - 61
  • [9] Depression and pain impair daily functioning and quality of life in patients with major depressive disorder
    Lin, Ching-Hua
    Yen, Yung-Chieh
    Chen, Ming-Chao
    Chen, Cheng-Chung
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 166 : 173 - 178
  • [10] Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment
    Lopez, Enrique
    Steiner, Alexander J.
    Manier, Karra
    Shapiro, Bryan B.
    Vanle, Brigitte
    Parisi, Thomas
    Dang, Jonathan
    Chang, Tiffany
    Ganjian, Shaina
    Mirocha, James
    Danovitch, Itai
    IsHak, Waguih William
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 225 : 117 - 122
12345